Alerta De Seguridad para Naturalyte Liquid Acid Concentrate and Naturalyte GranuFlo (powder) Acid Concentrate

Según Department of Health, este evento ( alerta de seguridad ) involucró a un dispositivo médico en Hong Kong que fue producido por Fresenius Medical Care North America.

¿Qué es esto?

Las alertas proporcionan información importante y recomendaciones sobre los productos. Aunque se haya emitido una alerta, esto no significa necesariamente que el producto se considera peligroso. Las alertas de seguridad, dirigidas a trabajadores de la salud y a usuarios, pueden incluir retiro de equipos. Pueden ser escritas por los fabricantes, pero también por funcionarios del área de salud.

Más información acerca de la data acá
  • Tipo de evento
    Safety alert
  • Fecha
    2012-06-28
  • Fecha de publicación del evento
    2012-06-28
  • País del evento
  • Fuente del evento
    DH
  • URL de la fuente del evento
  • Notas / Alertas
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • Notas adicionales en la data
    Medical Device Safety Alert
  • Causa
    Medical device safety alert: fresenius naturalyte liquid acid concentrate and naturalyte granuflo (powder) acid concentrate the united states food and drug administrations (fda) has issued a class i recall concerning naturalyte liquid acid concentrate and naturalyte granuflo (powder) acid concentrate distributed by fresenius medical care north america. please refer to the fda website for the affected serial numbers. the manufacturer is cautioning clinicians to be aware of the concentration of acetate or sodium diacetate (acetic acid plus acetate) contained in the products as mentioned above. inappropriate prescription of these products can lead to a high serum bicarbonate level in patients undergoing hemodialysis. this may contribute to metabolic alkalosis, which is a significant risk factor associated with low blood pressure, hypokalemia, hypoxemia, hypercapnia and cardiac arrhythmia, which, if not appropriately treated, may culminate in cardiopulmonary arrest. this product may cause serious adverse health consequences, including death. the fda recommended that health care providers should review the dialysate acid concentrate labeling for the specific concentrate that they prescribe to determine the components that can contribute to the patient's overall bicarbonate levels. according to the local supplier, the affected products were not distributed in hong kong. for details, please refer to fda websites: http://www.Fda.Gov/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/ ucm305630.Htm and http://www.Fda.Gov/medicaldevices/safety/listofrecalls/ucm309990.Htm if you are in possession of the product, please contact your supplier for necessary actions. posted on 28 june 2012.

Device

  • Modelo / Serial
  • Descripción del producto
    Medical Device Safety Alert: Fresenius Naturalyte Liquid Acid Concentrate and Naturalyte GranuFlo (powder) Acid Concentrate
  • Manufacturer

Manufacturer